StanleyN.CohenMD
Internal Medicine • Stanford, CAAdult Clinical & Laboratory Immunology
Professor, Genetics, Stanford University Medical Center
Are you Dr. Cohen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-5315Fax+1 650-725-1536
Summary
- Dr. Stanley Cohen, MD is an internist in Stanford, California. He is currently licensed to practice medicine in California. He is a Professor at Stanford University Medical Center.
Education & Training
Duke University HospitalResidency, Internal Medicine, 1964 - 1965
University of MichiganResidency, Internal Medicine, 1961 - 1962
Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 1960 - 1961
Perelman School of Medicine at the University of PennsylvaniaClass of 1960
Certifications & Licensure
CA State Medical License 1968 - 2025
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1988
Publications & Presentations
PubMed
- 2 citationsA Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab BiosimilarWalter Reinisch, Stanley N. Cohen, Monica Ramchandani, M. Khraishi, Jennifer Liu
Advances in Therapy. 2021-11-10 - 1 citationsA Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWO...Stanley N. Cohen, Viatcheslav R. Akmaev, Johanna B. Withers, Erin Connolly-Strong
Rheumatology and Therapy. 2021-11-10 - 25 citationsCalpain-dependent cytoskeletal rearrangement exploited for anthrax toxin endocytosis.Sun-Young Jeong, Mikhail Martchenko, Stanley N. Cohen
Proceedings of the National Academy of Sciences of the United States of America. 2013-10-15
Press Mentions
All or Something: Experts Debate LDA vs. Remission as a Target in Rheumatoid ArthritisApril 19th, 2022
Is Methotrexate Necessary with Tofacitinib?June 18th, 2019- EULAR 2019 - Day 1 ReportJune 12th, 2019
